Allied Cement’s Chinese Pharmaceutical Company Acquisition
Hong Kong (March 1, 2016) – Paul Hastings LLP, a leading global law firm, announced today that it represented Allied Cement Holdings Limited, a leading China-based cement manufacturing and trading company, to acquire 60% equity interests of Beijing Ziguang Pharmaceutical Co., Ltd. from Shenzhen Waranty Asset Management Co., Ltd. for US$44 million.
The acquisition is part of Allied Cement’s business strategy to expand into the medical, pharmaceutical and healthcare industry.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.